Comparative Study
doi: 10.1200/JCO.2001.19.4.1229.
Gemcitabine and cisplatin for advanced, metastatic bladder cancer
- PMID: 11181690
- DOI: 10.1200/JCO.2001.19.4.1229
Item in Clipboard
Comparative Study
Gemcitabine and cisplatin for advanced, metastatic bladder cancer
J Clin Oncol.
.
No abstract available
Comment on
-
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.J Clin Oncol. 1992 Jul;10(7):1066-73. doi: 10.1200/JCO.1992.10.7.1066. J Clin Oncol. 1992. PMID: 1607913 Clinical Trial.
-
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.J Clin Oncol. 1990 Jun;8(6):1050-5. doi: 10.1200/JCO.1990.8.6.1050. J Clin Oncol. 1990. PMID: 2189954 Clinical Trial.
-
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.J Clin Oncol. 2000 Sep;18(17):3068-77. doi: 10.1200/JCO.2000.18.17.3068. J Clin Oncol. 2000. PMID: 11001674 Corrected and republished. Clinical Trial.
Similar articles
-
Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma.J Clin Oncol. 2023 Aug 10;41(23):3879-3880. doi: 10.1200/JCO.23.00286. J Clin Oncol. 2023. PMID: 37549481 No abstract available.
-
Current and future perspectives in advanced bladder cancer: is there a new standard?Semin Oncol. 2002 Feb;29(1 Suppl 3):3-14. doi: 10.1053/sonc.2002.30750. Semin Oncol. 2002. PMID: 11894002 Review.
-
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.J Clin Oncol. 2005 Jul 20;23(21):4602-8. doi: 10.1200/JCO.2005.07.757. J Clin Oncol. 2005. PMID: 16034041 Clinical Trial.
-
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.Cancer. 2015 Aug 1;121(15):2586-93. doi: 10.1002/cncr.29387. Epub 2015 Apr 14. Cancer. 2015. PMID: 25872978
-
Treatment of metastatic urothelial cancer in the post-MVAC era.World J Urol. 2001 Apr;19(2):126-32. doi: 10.1007/s003450000193. World J Urol. 2001. PMID: 11374315 Review.
Cited by
-
Alkaloid from Alstonia yunnanensis diels root against gastrointestinal cancer: Acetoxytabernosine inhibits apoptosis in hepatocellular carcinoma cells.Front Pharmacol. 2023 Jan 11;13:1085309. doi: 10.3389/fphar.2022.1085309. eCollection 2022. Front Pharmacol. 2023. PMID: 36712668 Free PMC article.
-
Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere.Cancers (Basel). 2021 Jul 19;13(14):3615. doi: 10.3390/cancers13143615. Cancers (Basel). 2021. PMID: 34298829 Free PMC article. Review.
-
THZ1, a covalent CDK7 inhibitor, enhances gemcitabine-induced cytotoxicity via suppression of Bcl-2 in urothelial carcinoma.Am J Cancer Res. 2021 Jan 1;11(1):171-180. eCollection 2021. Am J Cancer Res. 2021. PMID: 33520367 Free PMC article.
-
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study.Cells. 2019 Oct 17;8(10):1268. doi: 10.3390/cells8101268. Cells. 2019. PMID: 31627336 Free PMC article.
-
Anti-cachectic effect of Antrodia cinnamomea extract in lung tumor-bearing mice under chemotherapy.Oncotarget. 2018 Apr 13;9(28):19584-19596. doi: 10.18632/oncotarget.24680. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29731967 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
